Skip to content

Time Course of Exhaled Hydrogen Concentration Following Oral Administration of a Hydrogen-Rich Jelly

Time Course of Exhaled Hydrogen Concentration Following Oral Administration of a Hydrogen-Rich Jelly - Time Course of Exhaled Hydrogen Concentration Following Oral Administration of a Hydrogen-Rich Jelly

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000061272
Enrollment
20
Registered
2026-04-15
Start date
2026-04-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Interventions

At the first test session, participants consume the same standardized commercially available meal, and at the second test session, they consume hydrogen-rich jelly (10 g containing 0.3 mg of hydrogen)

Sponsors

Hiroshima University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy

Exclusion criteria

Exclusion criteria: 1) Individuals currently taking medicines and/or dietary supplements 2) Individuals with food allergies 3) Individuals currently participating in another clinical study, or who have participated in another clinical study within the past 3 months 4) Individuals who are pregnant, may be pregnant, or are breastfeeding 5) Individuals judged by the principal investigator or sub-investigator to be ineligible for participation in this study

Design outcomes

Primary

MeasureTime frame
Increase in exhaled hydrogen concentration from baseline during 0-180 min following oral administration of hydrogen-rich jelly

Secondary

MeasureTime frame
- Cmax and AUC of the increase in exhaled hydrogen concentration from baseline during 0-180 min following oral administration of hydrogen-rich jelly - Postprandial increase in exhaled hydrogen concentration from baseline during 0-8 h, and its Cmax and AUC - Association between gut microbiome profiles and exhaled hydrogen and methane concentrations following oral administration of hydrogen-rich jelly

Countries

Japan

Contacts

Public ContactFumiko Higashikawa

Hiroshima University Hospital Medical Center for Translational and Clinical Research

healthy-life@hiroshima-u.ac.jp082-257-1909

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026